Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1652 1653
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18286067 | A Genus of Corynebacterium Microorganism for Producing L-Arginine and a Method for Producing L-Arginine Using the Same | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18523363 | COMPOSITION FOR IMPROVING, PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING NAMPT-DERIVED PEPTIDE AS ACTIVE INGREDIENT | Non-Final OA | Industry-University Cooperation Foundation Hanyang University ERICA Campus |
| 18466660 | METHODS AND COMPOSITIONS USEFUL FOR THE PRODUCTION OF 4-VINYLPHENOL | Non-Final OA | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC |
| 18701596 | OPTIMIZED BIOSYNTHESIS PATHWAY FOR CANNABINOID BIOSYNTHESIS | Non-Final OA | Cellibre, Inc. |
| 17767425 | MONO-HYDROXY OR DI-HYDROXY DERIVATIVES OF POLYUNSATURATED FATTY ACIDS, PRODUCTION METHOD THEREFOR, AND USE THEREOF | Non-Final OA | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
| 18519569 | FOOD AND DRUG COMPOSITION CONTAINING NOVEL ALDEHYDE DEHYDROGENASE FOR SUPPRESSING TREMOR OR MOVEMENT DISORDER | Non-Final OA | PICOENTECH Co., LTD. |
| 18285005 | CELL CULTURE PROCESS FOR FUSION PROTEIN COMPOSITION | Non-Final OA | DR. REDDY’S LABORATORIES LIMITED |
| 18166755 | METHODS OF PURIFYING A PRODUCT | Non-Final OA | Kodiak Sciences Inc. |
| 18085637 | INSTANT NUCLEIC ACID TEST METHOD AND TEST KIT FOR PATHOGENIC MUTANTS | Non-Final OA | Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences |
| 17719015 | High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier | Non-Final OA | University of Rhode Island Board of Trustees |
| 17768608 | RECOMBINANT POLYPEPTIDE FOR USE AS A MEDICINE, ANTISEPTIC AGENT, ANTIBACTERIAL AGENT, ANTI-INFLAMMATORY AGENT, COMPOSITIONS COMPRISING IT AND USES THEREOF | Final Rejection | MIEDZYNARODOWY INSTYTUT BIOLOGII MOLEKULARNEJ I KOMORKOWEJ W WARSZAWIE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy